Lack of CD54 expression and mutation of p53 gene relate to the prognosis of childhood Burkitt's lymphoma.
暂无分享,去创建一个
K. Yoshimoto | N. Kiyokawa | J. Fujimoto | M. Itakura | K. Sugita | Y. Kokai | H. Kaneko | K. Iizuka | K. Takada | M. Saito
[1] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[2] H. Koeffler,et al. p53 in hematologic malignancies. , 1994, Blood.
[3] V. Rotter,et al. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. , 1994, Blood.
[4] T. Yoshida,et al. OK-432-induced enhancement of ICAM-1 expression on tumor cells positively correlates to therapeutic effects for malignant effusion. , 1994, Clinical immunology and immunopathology.
[5] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[6] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[7] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[8] C. Bartram,et al. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. , 1993, Blood.
[9] H. J. Ree,et al. Intercellular adhesion molecule‐1 (ICAM‐1) staining of reactive and neoplastic follicles. ICAM‐1 expression of neoplastic follicle differs from that of reactive germinal center and is independent of follicular dendritic cells , 1993, Cancer.
[10] B. Caillou,et al. Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Société Française d'Oncologie Pédiatrique. , 1993, Blood.
[11] P. Herrlich,et al. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44 , 1993, The Journal of experimental medicine.
[12] G. Brittinger,et al. Follicular dendritic cells in non‐Hodgkin‐lymphoma express adhesion molecules complementary to ligands on neoplastic B‐cells , 1992, British journal of haematology.
[13] T. Sano,et al. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. , 1992, Cancer research.
[14] M. Maio,et al. Expression and functional role of CD54/Intercellular Adhesion Molecule-1 (ICAM-1) on human blood cells. , 1992, Leukemia & lymphoma.
[15] K. Bhatia,et al. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. , 1992, Cancer research.
[16] K. Hayashi,et al. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. , 1992, Blood.
[17] H. Hojo,et al. Expression of leukocyte adhesion molecules (ICAM‐1/LFA‐1) related to clinical behaviour in B cell lymphomas , 1992, Hematological oncology.
[18] R. Pieters,et al. Expression of the leucocyte integrin LFA-1 (CD11a/CD18) and its ligand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. , 1991, Leukemia.
[19] T. Crook,et al. p53 is frequently mutated in Burkitt's lymphoma cell lines. , 1991, The EMBO journal.
[20] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[21] G. Gaidano,et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Bishop. Molecular themes in oncogenesis , 1991, Cell.
[23] Timothy A. Springer,et al. Adhesion receptors of the immune system , 1990, Nature.
[24] N. Kiyokawa,et al. Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells , 1990, Clinical and experimental immunology.
[25] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[26] E. Ishii,et al. Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related. , 1988, Hybridoma.
[27] Y. Ishii,et al. Characterization of two distinct antigens expressed on either resting or activated human B cells as defined by monoclonal antibodies. , 1986, Clinical and experimental immunology.
[28] Murphy Sb. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. , 1980 .
[29] J. Ziegler. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. , 1977, The New England journal of medicine.
[30] D. Burkitt,et al. A sarcoma involving the jaws in african children , 1958, CA: a cancer journal for clinicians.
[31] M. Asada,et al. Clonal expansion of p53 mutant cells in leukemia progression in vitro. , 1994, Leukemia.
[32] R. Berger,et al. Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. , 1992, Leukemia.
[33] J. Zucker,et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] N. Kiyokawa,et al. Distinctive Pattern of Expression of Activation and Resting B Cell Antigens on Normal and Neoplastic Human B Cells: Immunophenotypic Heterogeneity in Some Lymphomas. , 1990, Leukemia & lymphoma.